National Comprehensive Cancer Network

NCCN Research & Business Resources

Oncology Research Program (ORP) Recent News

• NCCN Receives Research Grant to Evaluate Pralatrexate in Solid Tumors and Hematologic Malignancies (11/10/2009)
• NCCN Holds Oncology Research Best Practices Conference (9/14/2009)
• NCCN Oncology Research Program Celebrates 10th Anniversary by Closing in on $20 Million in Funding; Program Expands into Developmental Therapies (4/29/2009)

For questions about NCCN or for interview information, please contact Megan Martin 215.690.0576.

Oncology Research Program (ORP) News Archive

• NCCN Receives $4 Million Oncology Research Grant from Wyeth (1/15/2009)
• Combination Cancer Therapy is Focus of $1M Merck Research Grant Received by NCCN (12/1/2008)
• NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer (11/24/2008)
• NCCN, Abraxis BioScience and AstraZeneca Announce Collaboration to Conduct Anti-Cancer Drug Studies (10/7/2008)
• Is Cancer Community In Alignment About ‘Cure’ and ‘Costs’? NCCN Conference Panel Asks (3/7/2008)
• NCCN Receives Major Grant for Anti-Cancer Drug Study (11/15/2007)
• NCCN Receives $2 Million Grant from Pfizer (9/5/2006)
• NCCN and Roche Collaborate on Innovative Cancer Research (10/31/2005)
• Diane E. Paul, MS, RN, Joins National Comprehensive Cancer Network as Vice President, Clinical Trials Network (6/13/2005)
• Researchers Receive $1,886,237 in Funding from NCCN Clinical Trials Network (2/20/2003)
• The National Comprehensive Cancer Network Provides Physicians Easier Identification of Clinical Trials for Their Patients (11/5/2002)
• The National Comprehensive Cancer Network Launches Clinical Trials Network to Speed Drug Discovery (6/5/2002)
• Pharmacia Gives $3.15 Million Grant to NCCN to Advance Innovative Cancer Research Collaboration (1/1/2002)